Skip to content
A9168Assembly2023-2024 SessionSame asS6045

Create Infant Death Review Board

Official title

“Establishes a fetal and infant mortality review board”

Sponsor Chantel JacksonAD-79Affects Health
Status
In Assembly Committee
Health
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill establishes a Fetal and Infant Mortality Review Board in New York City to investigate and prevent fetal and infant deaths and morbidity.

Why it matters

  1. Focuses on addressing health disparities. The Review Board is specifically tasked with identifying and reducing fetal and infant mortality and morbidity driven by racial, economic, and other social injustices, aiming to improve outcomes for historically marginalized or underserved communities in NYC.

  2. Protects privacy and prevents punitive actions. All personally identifying information is removed before case review, and information collected cannot be used in civil, criminal, administrative, or family court proceedings against pregnant or birthing individuals, nor as grounds for child abuse reports, ensuring families are not penalized for adverse outcomes.

  3. Broad, multidisciplinary approach. The board must include diverse experts from various medical and public health fields, as well as those representing the city’s racial, ethnic, and socioeconomic diversity, ensuring recommendations are informed by a range of perspectives and experiences.

  4. Emphasizes actionable, systemic change. Beyond case review, the board is charged with issuing public reports, recommending improvements in services and policies, implementing surveillance to track trends, and advising on continuous quality improvement—potentially driving significant reforms in maternal and infant health care systems citywide.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • New York City health department

    The bill would establish a nine-member review board to examine fetal and infant deaths, review selected severe morbidity cases, and issue annual public findings and recommendations.

  • Likely support

    Hospitals, birthing facilities and medical examiners

    They would have to provide records requested by the commissioner to support reviews, with identifying information removed before transmission to the board.

  • Families experiencing pregnancy loss or infant death

    They could voluntarily submit information for reviews, with confidentiality protections and restrictions on using review information in court proceedings or child abuse reports.

  • Maternal and infant health equity advocates

    The board would recommend ways to address racial, economic and other disparities and identify systemic community conditions contributing to fetal and infant deaths.

Headline styles

Create Infant Death Review Board

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Chantel Jackson

Assembly Member · Assembly District 79

No co-sponsors yet.

History

  1. Print number 9168a
  2. Amend (t) and recommit to health
  3. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S6045Senate

Create Infant Death Review Board

In Senate Committee · Rules · Sponsor Jamaal Bailey

Impact 6 · Moderate0% to pass

Full text

4 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

9168--A

IN ASSEMBLY

February 12, 2024

Introduced by M. of A. JACKSON -- read once and referred to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee

AN ACT to amend the administrative code of the city of New York, in relation to establishing a fetal and infant mortality review board

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The administrative code of the city of New York is amended by adding a new section 17-166.1 to read as follows:

§ 17-166.1 Fetal and infant mortality review board. a. For the purposes of this section, unless the context requires otherwise:

(1) "Review board" means the fetal and infant mortality review board established by this section.

(2) "Fetal and infant death" means pregnancy loss that ends in miscarriage or stillbirth, or infant deaths within one year of birth.

(3) "Severe fetal and infant morbidity" or "morbidity" means unanticipated outcomes of pregnancy, labor, or delivery that result in significant short- or long-term consequences to a child's health.

b. There is hereby established in the department the fetal and infant mortality review board for the purpose of reviewing fetal and infant deaths and fetal and infant morbidity and developing and disseminating findings, recommendations, and best practices to contribute to the prevention of fetal and infant mortality and morbidity. The review board shall assess the cause of death, factors leading to death and preventability for each fetal and infant death reviewed and, in the discretion of the review board, cases of severe fetal and infant morbidity, and shall develop and disseminate strategies for reducing the risk of fetal and infant mortality and morbidity, including risk resulting from racial, economic, or other disparities. The commissioner may delegate the authority to conduct fetal and infant mortality reviews.

c. (1) The members of the review board shall be comprised of multidisciplinary experts in the field of fetal and infant mortality, fetal, neonatal and infant health and public health, maternal health, obstetrics and gynecology, and shall include health care professionals or

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD10351-03-4

other experts who serve and are representative of the racial, ethnic, and socioeconomic diversity of the city of New York and, to the extent possible, the medically underserved areas of the city of New York or areas of the city of New York with disproportionately high occurrences of fetal and infant mortality or morbidity.

(2) The review board shall be composed of nine members, all of whom shall be appointed by the commissioner.

(3) The terms of the review board members shall be three years. The commissioner may choose to reappoint review board members to additional three-year terms.

(4) A majority of the appointed membership of the review board, but no less than five, shall constitute a quorum.

(5) When any member of the review board fails to attend three consecutive regular meetings, unless good cause is shown for such absence, that membership may be deemed vacant for purposes of the appointment of a successor.

(6) Meetings of the review board shall be held at least twice a year but may be held more frequently as deemed necessary, subject to request of the department.

(7) Members of the review board shall be indemnified under section seventeen of the public officers law or section fifty-k of the general municipal law, as the case may be.

(8) Members of the review board shall not be compensated for their participation on the review board but shall receive reimbursement for their ordinary and necessary expenses of participation.

(9) Membership on the review board shall not disqualify any person from holding any public office or employment.

d. (1) The commissioner may request and shall receive upon request from any department, division, board, bureau, commission, local health department or other agency of the state or political subdivision thereof or any public authority, such information, including but not limited to death records, medical records, autopsy reports, toxicology reports, hospital discharge records, birth records and any other information that will help the department under this section to properly carry out its functions, powers and duties. The commissioner may request and shall receive upon request from any department, division, board, commission or other agency under the authority of the city of New York as well as hospitals established pursuant to article twenty-eight of the public health law, birthing facilities, medical examiners, coroners and coroner physicians and any other facility providing services associated with fetal and infant mortality or fetal and infant morbidity, such information, including, but not limited to, death records, medical records, autopsy reports, toxicology reports, hospital discharge records, birth records and any other information that will help the department under this section to properly carry out its functions, powers and duties.

(2) The commissioner shall receive and may solicit voluntary information, including oral or written statements, relating to any fetal and infant death and case of severe fetal and infant morbidity, from any family member or other interested party relating to any case that may come before the review board. Oral statements received under this paragraph shall be transcribed or summarized in writing. The commissioner shall transmit that information to the review board considering the case.

(3) Before transmitting any information to the review board, the commissioner shall remove all personal identifying information of the fetus or infant, individuals experiencing pregnancy loss or parents of the infant, health care practitioner or practitioners, or anyone else individually named in such information, as well as the hospital or facility that treated the fetus or infant, and any other information such as geographic location that may inadvertently identify the fetus or infant, fetus or infant's family, practitioner, or facility.

(4) Information received or transmitted under this section is not admissible in any civil, administrative, criminal, or family court proceeding that seeks to punish or prosecute the pregnant or birthing person and shall not be used as a basis of a report to the Statewide Central Register of Child Abuse and Maltreatment.

e. The review board:

(1) shall collect and perform case reviews of fetal and infant deaths;

(2) shall make and report findings and recommendations to the commissioner regarding the cause of death, factors leading to death, and preventability of each fetal or infant death case, and each case of severe fetal or infant morbidity reviewed by the review board, by reviewing relevant information for each case in the city of New York and consulting with experts as needed to evaluate the information for each death provided that no information which, alone or in combination, would permit an individual who experienced a pregnancy loss or infant death to be identified may be requested or shared with consulting experts, and that information reviewed or findings made by the board shall not be admissible in any civil, administrative, criminal, or family court proceeding and shall not be used as a basis of a report to the Statewide Central Register of Child Abuse and Maltreatment;

(3) shall develop and deliver to the commissioner recommendations on:

(A) issues of severe fetal and infant morbidity;

(B) addressing social determinants of fetal and infant health, including racial, economic or other historical and contemporary injustices which lead to disparities in fetal and infant outcomes;

(C) policies, best practices, and strategies to reduce fetal and infant mortality and morbidity;

(D) methods of improving services and resources; and

(E) methods of implementing continuous quality improvement in fetal and infant mortality and morbidity;

(4) shall issue an annual public report on its findings and recommendations and may also issue public reports more frequently;

(5) shall identify and address systemic community conditions contributing to fetal and infant deaths;

(6) shall implement a surveillance system to monitor incidence, etiologies, and contributing factors and which can describe effects of health care system change;

(7) shall identify system wide challenges to improving fetal and infant health care;

(8) may, in addition to the findings and recommendations made under this subdivision, and consistent with all applicable confidentiality protections, bring any particular matter to the attention of the commissioner; and

(9) may request and shall receive the assistance of the commissioner in carrying out its functions.

f. The commissioner and the review board shall each keep confidential any information collected or received under this section that includes personal identifying information of the fetus or infant, the fetus or infant's parents, health care practitioner or practitioners, or anyone else individually named in such information, as well as the hospital or facility that treated the fetus or infant, and any other information such as geographic location that may inadvertently identify the fetus or infant, the fetus or infant's parents, practitioner, or facility, and shall use the information provided or received under this section solely for the purposes of improvement of the quality of fetal and infant health care and to prevent fetal and infant mortality and morbidity. This subdivision shall not preclude the transmitting of information to the review board that is reasonably necessary to enable the review board to perform an appropriate review under this section. All records received, meetings conducted, reports, except those public reports required to be issued by the review board by this section, and records made and maintained and all books and papers obtained by the review board shall be confidential and shall not be made open or available, including under article six of the public officers law, and shall be limited to review board members as well as those authorized by the commissioner. Such information shall not be discoverable or admissible as evidence in any action in any court or before any other tribunal, board, agency or person.

g. The commissioner may use the recommendations and findings of the review board to develop guidance and other actions relating to best practices, and shall disseminate information relating to that guidance and other actions to appropriate health care providers.

§ 2. This act shall take effect one year after it shall have become a law.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.